Comparison of Low and High Dose Corticotropin Stimulation Tests in Patients with Pituitary Disease
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Tetracosactin [corticotropin-(1-24)] is used for clinical testing of adrenocortical responsiveness. The usual dose [high dose test (HDT)] is 250 micrograms. With this test, patients with mild secondary adrenal insufficiency are usually not identified, thus putting them at risk of an adrenal crisis in stressful situations. It was recently reported that a tetracosactin test with approximately 1 micrograms [low dose test (LDT)] identifies patients with mild forms of pituitary-adrenal insufficiency. We performed both the HDT and the LDT in 35 control subjects and in 44 patients with pituitary disease, mostly pituitary tumors. In these patients, more sensitive reference tests for evaluating the pituitary-adrenal axis (insulin-induced hypoglycemia, metyrapone, and CRH tests) were also performed. In the HDT, plasma cortisol was measured 30 and 60 min after tetracosactin injection; in the LDT (0.5 microgram/m2 body surface area), plasma cortisol was measured 20, 30, 40, 50, and 60 min postinjection. In 6 control subjects, tetracosactin plasma levels were also measured after injection. In the HDT, the correlation between 30 and 60 min cortisol levels was extremely high (r = 0.991; P < 0.0001), but the correlation of the LDT with the HDT at 30 min was also highly significant (r = 0.948; P < 0.0001). The lower normal limit of cortisol responses (means of controls minus 2 SD) at 30 min was lower in the LDT by 3.1 micrograms/dL (85 nmol/L) than in the HDT. Compared with the reference tests, the diagnostic sensitivities of the HDT and the LDT were almost identical. Both tests identified patients with moderately to severely pathological insulin and metyrapone tests, but not those with slightly pathological reference tests. In the HDT, plasma tetracosactin rose to more than 60,000 pg/mL shortly after injection. In the LDT, it rose to 1,900 pg/mL. Both concentrations stimulate cortisol (supra-) maximally. Together, these data show that in pituitary disorders the results of the LDT and the HDT are almost identical. Plasma tetracosactin levels in the LDT still rise to levels that maximally stimulate the adrenal. Tetracosactin testing with low or high doses cannot generally replace the more expensive and cumbersome insulin or metyrapone tests.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the stimulated serum cortisol concentrations differ considerably at 60 minutes between both conditions, with a further rise in the highdose test and a decrease of cortisol in the low-dose test (54,55).”
From Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [54]
In the citing paper
“This is not surprising since the high dose and low dose cosyntropin generate plasma ACTH concentrations of 22 000 to 100 000 pg/mL and 2000 pg/mL, respectively, at 2 minutes after injection [33, 34].”
From New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays (2021) · cites this paper as [34]
In the citing paper
“It has to be borne in mind that no test, including the ITT, can classify all subjects correctly (194, 199, 206 -209).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [206]
Citations
Cites
DICKSTEIN, G., SHECHNER, C., NICHOLSON, W. E., ROSNER, I., SHEN-ORR, Z., ADAWI, F., & LAHAV, M. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-4-773 · Cited by 457
Clinical review 62: Laboratory assessment of adrenal insufficiency.
Grinspoon, S. K., & Biller, B. M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962298 · Cited by 442
Broide, J. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.4.1243 · Cited by 269
A low dose ACTH test to assess the function of the hypothalamic–pituitary–adrenal axis
Rasmuson, S., Olsson, T., & Hägg, E. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.600482.x · Cited by 249
Tordjman, K. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.4.1301 · Cited by 219
Fiad, T. M., Kirby, J. M., Cunningham, S. K., & McKenna, T. J. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb03011.x · Cited by 168
Streeten, D. H. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.1.285 · Cited by 155
Borst, G. C., Michenfelder, H. J., & O'Brian, J. T. (1982) · New England Journal of Medicine · doi:10.1056/nejm198206173062405 · Cited by 111
Vestergaard, P., Hoeck, H., Jakobsen, P., & Laurberg, P. (1997) · Hormone and Metabolic Research · doi:10.1055/s-2007-979000 · Cited by 104
Adrenocorticotropic Effects of a Synthetic Polypeptide—β1–24-Corticotropin—in Man
LANDON, J., JAMES, V. H. T., CRYER, R. J., WYNN, V., & FRANKLAND, A. W. (1964) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-24-11-1206 · Cited by 100
Cited by
Items 201–218 of 218
Affrime, M. B. (2001) · CHEST Journal · doi:10.1016/s0012-3692(15)50195-5 · Cited by 1
Pituitary Surgery: Peri-operative Management
Barkan, A. L., BLANK, H. L., & Chandler, W. F. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-264-9_16 · Cited by 1
Kazachkova, I., Kong, D., Patel, K. N., Marcus, M., Pagala, M. K. D., Ten, S., & Kazachkov, M. Y. (2008) · Pediatric Asthma Allergy & Immunology · doi:10.1089/pai.2008.0511
The Development of a Non-invasive Short Synacthen Test
Elder, C. J. (2015) · UPT. Syiah Kuala University Library (Syiah Kuala University)
Pituitary Endocrine Function Testing
Ezzat, S. (2013) · Wiley eBooks · doi:10.1002/9781118559406.ch22
About the Use and Misuse of an ACTH 1-39 Radioimmunoassay to Measure ACTH 1-24
Grino, M., Darmon, P., Dadoun, F., Frachebois, C., Velut, J., Boullu, S., Dutour, A., & Oliver, C. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5472-10
Adrenal Insufficiency - Aetiology, Diagnosis and Treatment
Akter, N., & Qureshi, N. K. (2015) · Delta Medical College Journal · doi:10.3329/dmcj.v3i1.22238
Use of ACTH-(1-39) Radioimmunoassay to Measure ACTH-(1-24)--Authors' Response
Oelkers, W., & Bähr, V. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5472-11
Self-citationSoule, S. G. (2000) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2000.1186-2.x
Dangodara, A. A., & Muluk, V. S. (2011) · Springer eBooks · doi:10.1007/978-0-85729-498-2_22
Gerlach, H. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1367-1.00165-8
Manuylova, E., Calvi, L. M., Hastings, C., Vates, G. E., Stahlecker-Etter, M., Foxx, K. C., & Shafiq, I. (2016) · Journal of Endocrinology and Metabolism · doi:10.14740/jem366w
Oliver, C. (2009) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(09)70567-7
(1999) · Journal of Laboratory Medicine · doi:10.1515/labm.1999.23.7-8.415
Pérez, J. Á. D., Rodríguez-Hervada, A. D., de la Vega, I. R., & Novoa, M. P. D. M. (2004) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(04)70111-3
Eggertsdóttir Claessen, L. Ó. (2024) · Opin vísindi (Opin vísindi)
Hassan, A. A., Mubi, B., Dungus, M. M., Amali, A. O., Adamu, A. I., & Musa, A. H. (2026) · Nigerian Journal of Medicine · doi:10.4103/njm.njm_94_25
Kageyama, K., Sato, K., Yamagata, S., Tasso, M., Nakada, Y., & Sawada, S. (2026) · Clinical Case Reports · doi:10.1002/ccr3.73582
Metadata
- Authors
- Mayenknecht, J., Diederich, S., Bähr, V., Plöckinger, U., & Oelkers, W.
- Affiliations
- Freie Universität Berlin (DE)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1998-05
- Volume
- 83
- Issue
- 5
- Pages
- 1558-1562
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1992212028
- Semantic Scholar
- 48bae284abb12a09cc0d88f4d72013e759e5f814
- Cited by
- 142
- References
- 18
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 1 · 2023: 1 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 6 · 2017: 4 · 2016: 4 · 2015: 6 · 2014: 10 · 2013: 7 · 2012: 2
- FWCI
- 5.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- pituitary-adrenal axis, pituitary tumors, secondary adrenal insufficiency, metyrapone test, insulin-induced hypoglycemia test, diagnostic sensitivity, adrenal crisis
- MeSH terms
- Adult, Aged, Aged, 80 and over, Corticotropin-Releasing Hormone, Cosyntropin, Female, Humans, Hydrocortisone, Insulin, Kinetics, Male, Metyrapone, Middle Aged, Pituitary Diseases, Pituitary Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.